Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 719 - 734
Published: Dec. 28, 2024
Language: Английский
Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 378, P. 719 - 734
Published: Dec. 28, 2024
Language: Английский
International Journal of Biological Sciences, Journal Year: 2024, Volume and Issue: 20(11), P. 4458 - 4475
Published: Jan. 1, 2024
This study investigated the mechanism by which NR4A1 regulates mitochondrial fission factor (Mff)-related and FUN14 domain 1 (FUNDC1)-mediated mitophagy following cardiac ischemia-reperfusion injury(I/R). Our findings showed that damage regulation was positively correlated with pathological pan-apoptosis of myocardial cell mitochondria. Compared wild-type mice (WT), NR4A1-knockout exhibited resistance to injury fission, characterized activation. Results increased expression level, activating mediated Mff restoring phenotype FUNDC1. The inactivation FUNDC1 phosphorylation could not mediate normalization in a timely manner, leading an excessive stress response unfolded proteins imbalance homeostasis. process disrupted quality control network, accumulation damaged mitochondria activation pan-apoptotic programs. data indicate is novel critical target I/R exertsand negative regulatory effects Mff-mediated mito-fission inhibiting FUNDC1-mediated mitophagy. Targeting crosstalk balance between NR4A1-Mff-FUNDC1 potential approach for treating I/R.
Language: Английский
Citations
17Antioxidants, Journal Year: 2025, Volume and Issue: 14(3), P. 256 - 256
Published: Feb. 23, 2025
Endothelial dysfunction (ED) is characterized by an imbalance between vasodilatory and vasoconstrictive factors, leading to impaired vascular tone, thrombosis, inflammation. These processes are critical in the development of cardiovascular diseases (CVDs) such as atherosclerosis, hypertension ischemia/reperfusion injury (IRI). Reduced nitric oxide (NO) production increased oxidative stress key contributors ED. Aging further exacerbates ED through mitochondrial oxidative/nitrosative stress, heightening CVD risk. Antioxidant systems like superoxide-dismutase (SOD), glutathione-peroxidase (GPx), thioredoxin/thioredoxin-reductase (Trx/TXNRD) pathways protect against stress. However, their reduced activity promotes ED, vulnerability IRI. Metabolic syndrome, comprising insulin resistance, obesity, hypertension, often accompanied Specifically, hyperglycemia worsens endothelial damage promoting Obesity leads chronic inflammation changes perivascular adipose tissue, while associated with increase The NLRP3 inflammasome plays a significant role being triggered factors reactive oxygen nitrogen species, ischemia, high glucose, which contribute inflammation, injury, exacerbation Treatments, N-acetyl-L-cysteine, SGLT2 or inhibitors, show promise improving function. Yet complexity suggests that multi-targeted therapies addressing metabolic disturbances essential for managing CVDs syndrome.
Language: Английский
Citations
2Cell, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 1, 2024
Language: Английский
Citations
11Expert Opinion on Therapeutic Targets, Journal Year: 2025, Volume and Issue: unknown, P. 1 - 12
Published: Jan. 16, 2025
Introduction Cardiovascular disease (CVD) is the leading cause of death worldwide. Platelet-derived extracellular vesicles (PEV) have attracted extensive attention in cardiovascular research recent years because their cargo involved a variety pathophysiological processes, such as thrombosis, immune response, promotion or inhibition inflammatory angiogenesis well cell proliferation and migration.
Language: Английский
Citations
1Advanced Science, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 22, 2025
Abstract Precise and effective management of myocardial ischemia/reperfusion injury (MIRI) is still a formidable challenge in clinical practice. Additionally, real‐time monitoring drug aggregation the MIRI region remains an open question. Herein, delivery system, hesperadin ICG assembled PLGA‐Se‐Se‐PEG‐IMTP (HI@PSeP‐IMTP), designed to deliver for vivo optical imaging tracking ameliorate MIRI. The peak nanoprobes monitored by near‐infrared fluorescence photoacoustic imaging. maximal signals HI@PSeP‐IMTP group rise ≈32% 40% respectively compared with that HI@PSeP group. Moreover, effectively mitigates due synergistic integration diselenide bonds hesperadin, which can eliminate ROS suppress cardiac inflammation. Specifically, expression levels p‐CaMKII, p‐IκBα, p65 demonstrate reduction 30%, 46%, 42% PBS Collectively, provides new insights into development drugs integrating diagnosis treatment
Language: Английский
Citations
1ACS Applied Materials & Interfaces, Journal Year: 2024, Volume and Issue: 16(45), P. 61565 - 61582
Published: Nov. 1, 2024
Myocardial ischemia/reperfusion (MI/R) injury, a major contributor to poor prognosis in patients with acute myocardial infarction, currently lacks effective therapeutic strategies clinical practice. The long noncoding RNA (lncRNA) Oip5-as1 can regulate various cellular processes, such as cell proliferation, differentiation, and survival. may have potential target for MI/R injury its upregulated expression has been associated reduced infarct size improved cardiac function animal models, although how effectively safely overexpress vivo remains unclear. Lipid nanoparticles (LNPs) are versatile technology targeted drug delivery numerous applications. Herein, we aimed assess the efficacy safety of LNPs coloaded cardiomyocyte-specific binding peptide (LNP@Oip5-as1@CMP) murine model injury. To achieve this, LNP@Oip5-as1@CMP was synthesized via ethanol injection method. structural components were physicochemically analyzed. A hypoxia/reoxygenation (H/R) HL-1 cells coronary artery ligation mice used simulate Our results demonstrated that designed cardiomyocyte targeting efficient successfully synthesized. In cells, treatment significantly mitochondrial apoptosis caused by H/R model, intravenous administration decreased function. Mechanistic investigations revealed inhibited p53 signaling pathway. However, cardioprotective effects abrogated administrating Nutlin-3a, activator. Furthermore, no signs organ damage detected after injection. study reveals mitigating These findings pave way advanced treatments cardiovascular diseases, emphasizing promise lncRNA-based therapies.
Language: Английский
Citations
6Research Square (Research Square), Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 2, 2025
Language: Английский
Citations
0Clinical Hemorheology and Microcirculation, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 13, 2025
Objective: The aim of this study is to examine the impact controlled stepwise reperfusion by modulating pre-dilation balloon pressure during primary percutaneous coronary interventions (PPCI) in patients with ST-elevation myocardial infarction (STEMI). Methods: Consecutive STEMI requiring PPCI thrombolysis (TIMI) flow grades 0 or 1, were randomly divided into an experimental group and a control group. For group, was removed immediately after achieving antegrade perfusion beyond lesion. underwent reperfusion, being gradually reduced. Baseline data, intra/post-procedural 3-month left ventricular ejection fraction (LVEF), major adverse cardiac events (MACE) documented compared between two groups. Results: experienced more severe symptoms procedure ( p = 0.034), higher post-procedural corrected TIMI frame counts 0.047), significant hemodynamic changes 0.031), increased rates tachycardia/ventricular fibrillation 0.035). Additionally, they had total number arrhythmias 0.017), lower 90-min ST segment resolution rate 0.045), elevated cTNI levels one week 0.047). Three months later, demonstrated LVEF 0.048) trend towards drug-treated 0.073). No differences observed other statistical results. Conclusion: In undergoing PPCI, adjusting effectively reduces ischemia-reperfusion injury, improves perfusion, supports recovery function.
Language: Английский
Citations
0Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal Year: 2025, Volume and Issue: 1871(5), P. 167766 - 167766
Published: March 3, 2025
Language: Английский
Citations
0JACC Advances, Journal Year: 2025, Volume and Issue: 4(4), P. 101647 - 101647
Published: March 12, 2025
Language: Английский
Citations
0